In vivo magnetomotive optical molecular imaging using targeted magnetic nanoprobes

• DOI: 10.1073/pnas.0913679107
• Publication Date: 2010-04-20T03:40:15Z
• Authors: Renu John; Robabeh Rezaeipoor; Steven G. Adie; Eric J. Chaney; Amy L. Oldenburg; Marina Marjanovic; Justin P. Haldar; Bradley P. Sutton; Stephen A. Boppart
• Keywords: Receptor, ErbB-2; Contrast Media; Rats, Inbred WF; Magnetic Resonance Imaging; 01 natural sciences; Nanostructures; Rats; Magnetics; Microscopy, Electron, Transmission; Neoplasms; Models, Animal; 0103 physical sciences; Animals; Humans; Female; Tomography, Optical Coherence

Dynamic magnetomotion of magnetic nanoparticles (MNPs) detected with magnetomotive optical coherence tomography (MM-OCT) represents a new methodology for contrast enhancement and therapeutic interventions in molecular imaging. In this study, we demonstrate in vivo imaging of dynamic functionalized iron oxide MNPs using MM-OCT in a preclinical mammary tumor model. Using targeted MNPs, in vivo MM-OCT images exhibit strong magnetomotive signals in mammary tumor, and no significant signals were measured from tumors of rats injected with nontargeted MNPs or saline. The results of in vivo MM-OCT are validated by MRI, ex vivo MM-OCT, Prussian blue staining of histological sections, and immunohistochemical analysis of excised tumors and internal organs. The MNPs are antibody functionalized to target the human epidermal growth factor receptor 2 ( HER2 neu ) protein. Fc-directed conjugation of the antibody to the MNPs aids in reducing uptake by macrophages in the reticulo-endothelial system, thereby increasing the circulation time in the blood. These engineered magnetic nanoprobes have multifunctional capabilities enabling them to be used as dynamic contrast agents in MM-OCT and MRI.